Routinely reported antibiotics. Erythromycin/ clindamycin. Flucloxacillin/ dicloxacillin. Cefazolin / cephalexin
|
|
|
- Gregory Barber
- 5 years ago
- Views:
Transcription
1 John Hunter Hospital, 2017 # strains All isolates 8, % Some miscellaneous/contaminant species excluded. Escherichia coli 718 8% 58% 79% 77% R R n/a 85% 96% 93% 92% 92% 100% 94% R Klebsiella species 347 4% R 94% 71% R R n/a 97% 97% 95% 91% 97% 100% 97% R Enterobacter -like species* 720 8% R R R R R R 94% 96% ** 73% 89% 99% 97% R Pseudomonas aeruginosa 2,095 24% R R R R R R R 94% R 94% 94% 95% 92% R Haemophilus influenzae 1,674 19% 66% 89% n/a R R 99% 72% S 98% S S S S R Staphylococcus aureus- ALL 1,692 20% % 83% 95% 99% n/a Methicillin-susc. S. aureus 1,417 16% 16% S S 100% 87% 97% 100% n/a - S - S - 100% Methicillin-resistant S. aureus 275 3% R R R R 63% 85% 94% 87% R R R R - 100% 239 3% 100% S S S 97% 85% n/a R S S - S - S 483 6% 100% S S S 80% 25% n/a R S S - S - S % 100% S S S 76% 64% n/a R S S - S - S 178 2% 83% % 85% n/a R S S - S - S n/a not available - not routinely tested in this laboratory or no testing standard available 93% > 90% of isolates susceptible
2 Calvary Mater Hospital, July # strains All isolates 2, % Some miscellaneous/contaminant species excluded. Escherichia coli % 47% 74% 74% R R n/a 79% 93% 93% 93% 93% 100% 89% R Klebsiella species 119 6% R 92% 76% R R n/a 100% 98% 96% 89% 97% 100% 98% R Enterobacter -like species* 88 4% R R R R R R 93% 98% ** 86% 85% 100% 98% R Pseudomonas aeruginosa 181 9% R R R R R R R 96% R 95% 96% 98% 93% R Haemophilus influenzae % 62% 88% n/a R R 99% 70% S 99% S S S S R Staphylococcus aureus- ALL % % 86% 97% 100% n/a Methicillin-susc. S. aureus % 19% S S 100% 88% 98% 100% n/a - S - S - 100% Methicillin-resistant S. aureus 151 7% R R R R 74% 94% 99% n/a R R R R - 100% 103 5% 100% S S S 95% 87% n/a R S S - S - S 48 2% 100% S S S 79% 32% n/a R S S - S - S 53 3% 100% S S S 81% 69% n/a R S S - S - S 130 6% 85% % 83% n/a R S S - S - S
3 Lower and Upper Hunter Valley Sectors including Maitland and Belmont Hospitals, 2017 All isolates 2, % Some miscellaneous/contaminant species excluded. Escherichia coli 211 7% 51% 79% 72% R R n/a 78% 91% 91% 96% 92% 100% 84% R Klebsiella species 59 2% R 92% 74% R R n/a 95% 95% 97% 92% 95% 100% 95% R Enterobacter -like species* 49 2% R R R R R R 98% 98% ** 85% 90% 100% 96% R Pseudomonas aeruginosa 163 6% R R R R R R R 96% R 93% 93% 97% 91% R Haemophilus influenzae 217 8% 65% 83% n/a R R 99% 75% S 99% S S S S R Staphylococcus aureus- ALL 1,367 48% % 86% 96% 99% n/a Methicillin-susc. S. aureus 1,098 38% 16% S S 100% 89% 97% 100% n/a - S - S - 100% Methicillin-resistant S. aureus 269 9% R R R R 74% 92% 99% n/a R R R R - 100% % 100% S S S 94% 90% n/a R S S - S - S 240 8% 100% S S S 85% 19% n/a R S S - S - S % 100% S S S 100% 70% n/a R S S - S - S 167 6% 85% % 76% n/a R S S - S - S
4 Tamworth Hospital and Peel Sector, July # strains All isolates 2, % Some miscellaneous/contaminant species excluded. Escherichia coli 202 8% 59% 90% 90% R R n/a 87% 96% 94% 92% 0% 100% 95% R Klebsiella species 77 3% R 91% 78% R R n/a 92% 95% 91% 90% 100% 100% 96% R Enterobacter -like species* 107 5% R R R R R R 90% 92% ** 21% 0% 100% 99% R Pseudomonas aeruginosa 220 9% R R R R R R R 96% R 99% 96% 97% 93% R Haemophilus influenzae 140 6% 64% 88% n/a R R 99% 65% S 98% S S S S R Staphylococcus aureus- ALL 1,007 42% % 87% 97% 98% n/a Methicillin-susc. S. aureus % 20% S S 100% 89% 98% 99% n/a - S - S - 100% Methicillin-resistant S. aureus 199 8% R R R R 78% 89% 94% n/a R R R R - 100% % 100% S S S 99% 89% n/a R S S - S - S 132 6% 100% S S S 82% 23% n/a R S S - S - S % 100% S S S 91% 64% n/a R S S - S - S 110 5% 99% % 89% n/a R S S - S - S
5 Maitland Hospital and Lower Hunter Sector, 2017 All isolates 2, % Some miscellaneous/contaminant species excluded. Escherichia coli % 54% 81% 78% R R n/a 78% 93% 96% 93% 94% 100% 89% R Klebsiella species 70 3% R 96% 73% R R n/a 96% 97% 97% 96% 94% 100% 96% R Enterobacter -like species* 59 2% R R R R R R 96% 97% ** 90% 86% 100% 100% R Pseudomonas aeruginosa 150 6% R R R R R R R 97% R 95% 96% 97% 91% R Haemophilus influenzae 189 7% 61% 82% n/a R R 100% 70% S 98% S S S S R Staphylococcus aureus- ALL 1,099 43% % 85% 96% 99% n/a Methicillin-susc. S. aureus % 16% S S 100% 88% 97% 100% n/a - S - S - 100% Methicillin-resistant S. aureus 216 8% R R R R 74% 91% 98% n/a R R R R - 100% % 100% S S S 93% 88% n/a R S S - S - S 178 7% 100% S S S 83% 15% n/a R S S - S - S % 100% S S S 100% 70% n/a R S S - S - S 153 6% 86% % 77% n/a R S S - S - S
6 Manning Base Hospital, LMNC Sector, July All isolates 1, % Some miscellaneous/contaminant species excluded. Escherichia coli % 54% 82% 79% R R n/a 81% 93% 94% 95% 95% 100% 92% R Klebsiella species 55 3% R 93% 79% R R n/a 93% 100% 96% 88% 98% 100% 98% R Enterobacter -like species* 66 4% R R R R R R 94% 93% ** 89% 85% 100% 95% R Pseudomonas aeruginosa 127 7% R R R R R R R 94% R 92% 93% 94% 94% R Haemophilus influenzae 163 9% 66% 89% n/a R R 99% 77% S 99% S S S S R Staphylococcus aureus- ALL % % 85% 97% 99% n/a Methicillin-susc. S. aureus % 15% S S 100% 85% 98% 100% n/a - S - S - 100% Methicillin-resistant S. aureus 154 9% R R R R 84% 95% 98% n/a R R R R - 100% 144 8% 100% S S S 97% 78% n/a R S S - S - S 64 4% 100% S S S 83% 47% n/a R S S - S - S % 100% S S S 90% 65% n/a R S S - S - S 130 7% 88% % 88% n/a R S S - S - S
7 Armidale Hospital and Tablelands Sector, July All isolates 1, % Some miscellaneous/contaminant species excluded. Escherichia coli 93 6% 61% 84% 88% R R n/a 96% 96% 95% 95% 89% 100% 95% R Klebsiella species 35 2% R 100% 69% R R n/a 100% 100% 100% 97% 100% 100% 100% R Enterobacter-like species* 38 3% R R R R R R 88% 97% ** 50% 100% 97% 100% R Pseudomonas aeruginosa 72 5% R R R R R R R 99% R 96% 92% 96% 93% R Haemophilus influenzae 96 7% 74% 89% n/a R R 99% 75% S 99% S S S S R Staphylococcus aureus- ALL % % 98% 92% 98% n/a Methicillin-susc. S. aureus % 21% S S 100% 99% 94% 99% n/a - S - S - 100% 355 Methicillin-resistant S. aureus 100 7% R R R R 96% 84% 96% n/a R R R R - 100% % 100% S S S 97% 88% n/a R S S - S - 100% 73 5% 100% S S S 76% 18% n/a R S S - S - 100% % 100% S S S 86% 61% n/a R S S - S - 100% 63 4% 92% % 91% n/a R S S - S - 100%
8 Northern NSW (all sites) 2017 All isolates 6, % Some miscellaneous/contaminant species excluded. Escherichia coli 358 6% 53% 81% 67% R R n/a 80% 94% 92% 95% 92% 100% 87% R Klebsiella species 143 2% R 93% 72% R R n/a 97% 99% 94% 95% 97% 100% 89% R Enterobacter-like species* 212 3% R R R R R R 94% 94% ** 85% 84% 100% 83% R Pseudomonas aeruginosa % R R R R R R R 95% R 90% 94% 97% 91% R Haemophilus influenzae 305 5% 60% 86% n/a R R 99% 77% S 98% S S S S R Staphylococcus aureus- ALL 3,298 51% % 85% 96% 98% n/a Methicillin-susc. S. aureus 2,731 42% 18% S S 100% 87% 97% 99% n/a - S - S - 100% Methicillin-resistant S. aureus 567 9% R R R R 77% 92% 95% n/a R R R R - 100% % 100% S S S 95% 68% n/a R S S - S - S 186 3% 100% S S S 71% 17% n/a R S S - S - S 199 3% 100% S S S 87% 73% n/a R S S - S - S 340 5% 85% % 89% n/a R S S - S - S
9 Mid-North Coast (all sites) 2017 All isolates 3, % Some miscellaneous/contaminant species excluded. Escherichia coli 188 5% 57% 81% 82% R R n/a 79% 93% 89% 86% n/a 100% 90% R Klebsiella species 57 2% R 82% 72% R R n/a 86% 91% 86% 88% n/a 100% 94% R Enterobacter -like species* 84 2% R R R R R R 98% 98% ** 42% n/a 99% 98% R Pseudomonas aeruginosa % R R R R R R R 98% R 98% 97% 96% 97% R Haemophilus influenzae 209 6% 72% 91% n/a R R 100% 74% S 99% S S S S R Staphylococcus aureus- ALL 1,966 57% % n/a 96% 98% n/a Methicillin-susc. S. aureus 1,573 46% 15% S S 100% 88% 98% 98% n/a - S - S - 100% Eryth Methicillin-resistant S. aureus % R R R R 77% 91% 96% n/a R R R R - 100% Clinda % 100% S S S 97% 76% n/a R S S - S - S 34 1% 100% S S S 88% 22% n/a R S S - S - S 79 2% 100% S S S 87% 71% n/a R S S - S - S 80 2% 95% % 81% n/a R S S - S - S
Notice Inviting Limited Tender Enquiry
ALL INDIA INSTITUTE OF MEDICAL SCIENCES (AIIMS) BHOPAL SAKET NAGAR, BHOPAL-462 020 (MP) INDIA www.aiimsbhopal.edu.in Email: etender@aiimsbhopal.edu.in Limited Tender Enquiry No. :AIIMS Bhopal/HC/MSO/2016-17/003
ORIGINAL ARTICLE /j x
ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01377.x Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values J. Turnidge 1, G. Kahlmeter
JOINING FORCES TO CREATE A LEADING COMMERCIAL-STAGE COMPANY. Focused on Anti-Infectives
JOINING FORCES TO CREATE A LEADING COMMERCIAL-STAGE COMPANY Focused on Anti-Infectives CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS Certain statements in this communication regarding the proposed
Taiwantrade Supplier Business Information Verification Report
Taiwantrade Supplier Business Information Verification Report Company Address: City / Country: Contact Person: Phone Number: Presented to MACROHI CO. LTD. 美科實業有限公司 12F.-1, No.293-1, Sec. 1, Zhongshan Rd.,
Facility State National
Percentage Summary Report Page 1 of 5 Data As Of: 09/12/2018 Total Facility State National 31.416666666667 39.359722222222 38.095746590093 Unweighted Domain Weighting Weighted Domain Clinical Care Domain
Dashboard Terminology. December 2017
Dashboard Terminology December 2017 Contents Green Boundary O/E Ratio Equity Ratio Ideal Level Standard Deviation Z-Score Statistical process control SPC methods Run chart Control chart Cumulative sum
Ayrshire and Arran NHS Board
Paper 15 Ayrshire and Arran NHS Board Monday 19 May 2014 Performance Governance Committee Annual Report for 2013-14 Author: Helen Strainger-Boyce, Performance Manager / Frances Ewan, Planning and Performance
Final Rule Summary. Medicare Long-Term Care Hospital Prospective Payment System Program Year: 2019
Final Rule Summary Medicare Long-Term Care Hospital Prospective Payment System Program Year: 2019 August 2018 1 TABLE OF CONTENTS Overview and Resources... 2 LTCH Payment Rate... 2 Changes to the Site-Neutral
Biosenta Inc. MANAGEMENT DISCUSSION AND ANALYSIS FOR THE THREE MONTHS ENDED DECEMBER 31, 2014 AND 2013
Biosenta Inc. MANAGEMENT DISCUSSION AND ANALYSIS FOR THE THREE MONTHS ENDED DECEMBER 31, 2014 AND 2013 The following management discussion and analysis ( MD&A ) of financial results is dated March 2, 2015
For personal use only
2017 ANNUALREPORT ABN 73 124 849 065 2017 HIGHLIGHTS Dose safety indicated in multiple animal models Efficacy in animal models for superbug strains of E. coli and S. Aureus Multiple tests of mutagenicity
Medicare Long-Term Care Hospital Prospective Payment System
Medicare Long-Term Care Hospital Prospective Payment System Payment Rule Brief FINAL RULE Program Year: FFY 2016 Overview and Resources On August 17, 2015, the Centers for Medicare and Medicaid Services
SUMMARY: The Internet has become the means for disseminating the entirety of the Department of
This document is scheduled to be published in the Federal Register on 06/11/2018 and available online at https://federalregister.gov/d/2018-11251, and on FDsys.gov DEPARTMENT OF LABOR Office of the Secretary
Medicare Long-term Care Hospital Prospective Payment System Fiscal Year 2016
Final Rule Summary Medicare Long-term Care Hospital Prospective Payment System Fiscal Year 2016 February 2016 1 P a g e Table of Contents Overview and Resources... 2 Effect of BiBA and PAMA on the LTCH
26 April 2018 ASX RELEASE QUARTERLY REPORT FOR THE PERIOD ENDED 31 MARCH 2018
Zoono Group Limited ABN: 73 006 645 754 Level 12 225 George Street Sydney NSW 2000 T: +61 (2) 8042 8481 www.zoono.com 26 April 2018 ASX RELEASE Highlights in QUARTERLY REPORT FOR THE PERIOD ENDED 31 MARCH
Actavis to Acquire Durata Therapeutics, Inc.
October 6, 2014 Actavis to Acquire Durata Therapeutics, Inc. - Lead Product DALVANCE a Novel Antibiotic for Unmet Medical Need in Hospital and Outpatient Settings - - Enhances Actavis' Long-term Growth
Final Rule Summary. Medicare Inpatient Rehabilitation Facility Prospective Payment System Program Year: FY2018
Final Rule Summary Medicare Inpatient Rehabilitation Facility Prospective Payment System Program Year: FY2018 August 2017 1 TABLE OF CONTENTS Overview and Resources... 2 IRF Payment Rate... 2 Wage Index,
Jobs for NSW. Regional Growth Loans. Frequently Asked Questions
Jobs for NSW Regional Growth Loans Frequently Asked Questions What is a Regional Growth Loan? Regional Growth Loans (RGL) aim to drive jobs and business growth by providing emerging scalable fast growth
Please include payment with your samples. Street Address: Certified Check Money Order Credit Card Address 2:
SAMPLE SUBMITTAL FORM EMSL ORDER NUMBER (LAB USE ONLY) 2756 SLOUGH STREET MISSISSAUGA, ON L47 1G3 Your Name: Please include payment with your samples. Street Address: Certified Check Money Order Credit
CEMPRA, INC. FORM DEFA14A. (Additional Proxy Soliciting Materials (definitive)) Filed 09/11/17
CEMPRA, INC. FORM DEFA14A (Additional Proxy Soliciting Materials (definitive)) Filed 09/11/17 Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL, NC, 27517-8149 Telephone 919-576-2306 CIK 0001461993 Symbol
Medicare Inpatient Rehabilitation Facility Prospective Payment System
Medicare Inpatient Rehabilitation Facility Prospective Payment System Payment Rule Brief PROPOSED RULE Program Year: FFY 2018 Overview and Resources On May 3, 2017, the Centers for Medicare and Medicaid
For personal use only
Our Mission: To target the global health problem of superbugs One of the greatest threats of human health today World Health Organisation ASX: RCE 1 Disclaimer ALL CURRENCY AMOUNTS ARE IN AUD UNLESS STATED
Zacks Small-Cap Research
Zacks Small-Cap Research Sponsored Impartial - Comprehensive January 9, 2019 David Bautz, PhD 312-265-9471 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 ContraFect Corp. (CFRX-NASDAQ)
MR #: Patient Name: Page: 1 of 4 CAPE COD HAND & UPPER EXTREMITY THERAPY PATIENT DATA SHEET
MR #: Patient Name: Page: 1 of 4 CAPE COD HAND & UPPER ETREMITY THERAPY PATIENT DATA SHEET First: MI: Last: Date of Birth: Age: Gender: Male Female Mailing Address: Physical Address: May we send you text
Medicare Long-term Care Hospital Prospective Payment System Fiscal Year 2017
Final Rule Summary Medicare Long-term Care Hospital Prospective Payment System Fiscal Year 2017 August 2016 1 P a g e TABLE OF CONTENTS Overview and Resources... 1 Effect of BiBA and PAMA on the LTCH PPS...
VIROPHARMA INCORPORATED TO ACQUIRE U.S. VANCOCIN BRAND FROM LILLY
Contacts: Vincent Milano Chief Financial Officer Phone (610) 321-6225 Will Roberts Director, Corporate Communications Phone (610) 321-6288 VIROPHARMA INCORPORATED TO ACQUIRE U.S. VANCOCIN BRAND FROM LILLY
Clinical Policy: Vancomycin Oral (Vancocin) Reference Number: CP.CPA.166 Effective Date: Last Review Date: 11.18
Clinical Policy: (Vancocin) Reference Number: CP.CPA.166 Effective Date: 11.16.16 Last Review Date: 11.18 Line of Business: Commercial Revision Log See Important Reminder at the end of this policy for
RESEARCH WINS. LIFE WINS.
RESEARCH WINS. LIFE WINS. Wockhardt Bio AG Grafenauweg 6 6300 Zug Switzerland Phone +41 41 727 5220 Fax +41 41 727 5221 www.wockhardtbio.com Annual Report 2015-16 Globally, drug-resistant infections have
Medicare Long-Term Care Hospital Prospective Payment System
Medicare Long-Term Care Hospital Prospective Payment System Payment Rule Brief Proposed Rule Program Year: FFY 2014 Overview On May 10, 2013, the Centers for Medicare and Medicaid Services (CMS) released
Best Time To Call. Referring Physician:
Page: 1/6 EXCEL PHYSICAL THERAPY PATIENT DATA SHEET DO NOT EMAIL The electronic form is provided for your convenience. With respect to responding to this form, please do not send via email. Please populate,
Medicare Long Term Care Hospital Prospective Payment System
Medicare Long Term Care Hospital Prospective Payment System Payment Rule Brief FINAL RULE Program Year: FFY 2014 Overview and Resources On August 19, 2013, the Centers for Medicare and Medicaid Services
See Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Sivextro) Reference Number: CP.PMN.62 Effective Date: 03.01.15 Last Review Date: 02.18 Line of Business: Health Insurance Marketplace, Medicaid Revision Log See Important Reminder at
LIMITED COVERAGE FOR LOSS BY WET ROT, DRY ROT, BACTERIA, FUNGI, OR PROTISTS
This endorsement changes the policy Page 1 of 7 -- PLEASE READ THIS CAREFULLY -- LIMITED COVERAGE FOR LOSS BY WET ROT, DRY ROT, BACTERIA, FUNGI, OR PROTISTS 1. The following exclusion is added under item
The Outlook for the Housing Industry in New South Wales
The Outlook for the Housing Industry in New South Wales Harley Dale HIA Chief Economist HIA Industry Outlook Breakfast Sydney March 2011 It s (apparently) all about Europe What s going on in Europe and
ANTIMICROBIAL NANO-TECHNOLOGY
ANTIMICROBIAL NANO-TECHNOLOGY ZOONO GROUP LIMITED MARCH 2017 DISCLAIMER This Investor presentation has been prepared solely for the purpose of assisting recipients in deciding whether to investigate further
2015 Annual General Meeting. October2015
2015 Annual General Meeting October2015 FY15 Results Significant restructuring and capital management to support profit recovery in FY16. Statutory EBIT loss of $33.2m Statutory NPAT loss of $36.9m Trading
Oragenics, Inc. (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: September 27, 2018
IV. JUSTIFICATION: Standard/Required Item Board Request New Item New Topic from Staff
333 Bush Street San Francisco, CA 94104 (415) 263-5400 www.statefundca.com Date: September 12, 2014 TO: MEMBERS, BOARD OF DIRECTORS I. AGENDA ITEM # AND TITLE : Open Agenda Item 3d Consent Calendar: Legislative
PLAN MANAGEMENT ADVISORY GROUP June 13, 2016
PLAN MANAGEMENT ADVISORY GROUP June 13, 2016 WELCOME AND AGENDA REVIEW BRENT BARNHART, CHAIR PLAN MANAGEMENT ADVISORY GROUP 1 AGENDA AGENDA Plan Management and Delivery System Reform Advisory Group Meeting
SUMMARY: The Internet has become the means for disseminating the entirety of the Department of
This document is scheduled to be published in the Federal Register on 08/24/2017 and available online at https://federalregister.gov/d/2017-17060, and on FDsys.gov DEPARTMENT OF LABOR Office of the Secretary
Samaritans Regional Rental Affordability Snapshot. Central Coast, Newcastle/Lake Macquarie, Hunter (incl. Port Stephens) and Mid-Coast
Samaritans Regional Rental Affordability Snapshot Central Coast, Newcastle/Lake Macquarie, Hunter (incl. Port Stephens) and Mid-Coast 2018 Samaritans Regional Rental Affordability Snapshot Central Coast,
MR #: Patient Name: Page: 1 of 4 MADISON SPINE & PHYSICAL THERAPY PATIENT DATA SHEET
MR #: Patient Name: Page: 1 of 4 MADISON SPINE & PHYSICAL THERAPY PATIENT DATA SHEET First: MI: Last: Date of Birth: Age: Gender: Male Female Mailing Address: Physical Address: May we send you text messages
Snapshot: The Samaritans Foundation Central Coast, Newcastle/Lake Macquarie, Hunter (incl. Port Stephens) and Mid-Coast
Snapshot: The Samaritans Foundation Central Coast, Newcastle/Lake Macquarie, Hunter (incl. Port Stephens) and Mid-Coast Introduction The Rental Affordability Snapshot is an annual national initiative of
MR #: Patient Name: Page: 1 of 4 ADVANCED PHYSICAL THERAPY PATIENT DATA SHEET. May we send you text messages relating to your care with us?
MR #: Patient Name: Page: 1 of 4 ADVANCED PHYSICAL THERAPY PATIENT DATA SHEET First: MI: Last: Date of Birth: Age: Gender: Male Female Mailing Address: Physical Address: May we send you text messages relating
MR #: Patient Name: Page: 1 of 4 HAMILTON PHYSICAL THERAPY SERVICES PATIENT DATA SHEET
MR #: Patient Name: Page: 1 of 4 HAMILTON PHYSICAL THERAPY SERVICES PATIENT DATA SHEET First: MI: Last: Date of Birth: Age: Gender: Male Female Mailing Address: Physical Address: May we send you text messages
4303. Benefits... (j)(1) A health service corporation or medical expense indemnity corporation which provides medical, major-medical or similar
SUMMARY TABLE NEW YORK PROPOSED LANGUAGE Covered Services: To the extent permitted by federal law, any health benefit plan issued, renewed, extended, or modified for delivery in this state, must include
Medicare s RRP and HAC Programs
Medicare s RRP and HAC Programs Tennessee Hospital Association DataGen Susan McDonough Lauren Davis June 27, 2017 Today s Objectives Overview of Medicare Readmission Reduction and Hospital Acquired Condition
Invitation to Bid CLEANING CHEMICALS
Invitation to Bid 120215 CLEANING CHEMICALS Responses to an Invitation to Bid will be received by the Purchasing Supervisor, Sumner County Board of Education, 1500 Airport Road, Gallatin, TN 37066 for
THE SHELL COMPANY OF AUSTRALIA (SCOA) POLLUTION INCIDENT RESPONSE MANAGEMENT PLAN - NEWCASTLE TERMINAL
THE SHELL COMPANY OF AUSTRALIA (SCOA) POLLUTION INCIDENT RESPONSE MANAGEMENT PLAN - NEWCASTLE TERMINAL FINAL 1 SEPTEMBER 2012 The Shell Company of Australia Limited 2011 DEFINITIONS EPA PIRMP Environment
DECISION BETWEEN SOUTH ALDER HOLDINGS LTD. APPELLANT AND: BRITISH COLUMBIA CHICKEN MARKETING BOARD RESPONDENT APPEARANCES: Dave Merz, Member
IN THE MATTER OF THE NATURAL PRODUCTS MARKETING (BC) ACT AND AN APPEAL BY SOUTH ALDER HOLDINGS LTD. FROM A DECISION CONCERNING A DENIAL OF RELIEF OF A89 UNDER PRODUCTION BETWEEN SOUTH ALDER HOLDINGS LTD.
Innovating for the healthcare needs of today and tomorrow. Q3 presentation 12 November 2015
1 Innovating for the healthcare needs of today and tomorrow Q3 presentation 12 November 2015 Antibiotic resistance and healthcare associated infections at the top of the political agenda 2 Global consumption
L 303/40 Official Journal of the European Union
L 303/40 Official Journal of the European Union 14.11.2013 COMMISSION IMPLEMENTING DECISION of 12 November 2013 as regards a Union financial aid towards a coordinated control plan for antimicrobial resistance
Human Resources Department Division of Risk Management Annual Report
Human Resources Department Division of Risk Management Annual Report Ending June 30, 2009 City of Sacramento TABLE OF CONTENTS Executive Summary... 1 Risk Management Mission Statement... 2 Risk Management
QUARTERLY REPORT VALNEVA SE
Q1 2015 QUARTERLY REPORT VALNEVA SE May 12, 2015 VALNEVA SE Gerland Plaza Techsud 70, rue Saint Jean de Dieu 69007 Lyon, France www.valneva.com VALNEVA SE Q1 2015 1 VALNEVA REPORTS STRONG Q1 2015 FINANCIAL
Shareholder information
Shareholder information Spire Healthcare website Shareholders are encouraged to visit our website at www.spirehealthcare.com which has a wealth of information about the Company and the services it offers.
See Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: CP.PHAR.388 Effective Date: 12.01.18 Last Review Date: 02.19 Line of Business: Commercial, HIM, Medicaid Coding Implications Revision Log See Important Reminder at the
Medicare s RRP and HAC Programs
Medicare s RRP and HAC Programs Michigan Health and Hospital Association DataGen Susan McDonough Bill Shyne Lauren Davis January 25, 2017 Today s Objectives Overview of Medicare Readmission Reduction and
10. Haemophilus influenzae B, and 11. Hepatitis A. (2) COVERED AGE GROUPS
SUMMARY TABLE-- DELAWARE PROPOSED LANGUAGE Covered Services: To the extent permitted by federal law, any health benefit plan issued, renewed, extended, or modified for delivery in this state, must include
For personal use only
Healthscope Limited ACN 144 840 639 Level 1, 312 St Kilda Road Melbourne Victoria 3004 Tel: (03) 9926 7500 Fax: (03) 9926 7533 www.healthscope.com.au APPENDIX 4D RESULTS FOR ANNOUNCEMENT TO THE MARKET
DUTY DISABILITY FIREFIGHTER SURVIVOR BENEFITS KNOWING ABOUT HAWKS QUINDEL, S.C. Daniel R. Schoshinski Summer H. Murshid
KNOWING ABOUT DUTY DISABILITY & FIREFIGHTER SURVIVOR BENEFITS Daniel R. Schoshinski Summer H. Murshid HAWKS QUINDEL, S.C. Milwaukee: (414) 271-8650 or (800) 236-3348 Madison: (608) 257-0040 or (800) 610-0040
Annexure - Catholic Schools Intrastate Long Service Leave Portability Arrangement
Annexure - Catholic Schools Intrastate Long Service Leave Portability Arrangement 1. Application 1.1 This Annexure shall apply to: (a) (b) The Employers listed in Clause 6 of this Annexure; and Any person
Sanofi-aventis press release
Sanofi-aventis press release Sanofi-aventis delivers double-digit EPS 1 growth in 2009 as the Transformation program progresses Paris, February 10, 2010 2009 Change on a reported basis Q4 2009 Change on
Prepare Your Lab for PAMA: Understand How Your Costs Compare to New Reimbursements! Brad Brimhall, MD, MPH March 21, 2017
Prepare Your Lab for PAMA: Understand How Your Costs Compare to New Reimbursements! Brad Brimhall, MD, MPH March 21, 2017 Financial Center Schizophrenia in the Lab Revenue Center Inpatient Expense/Cost
QUESTION: What is my deductible?
QUESTION: What is my deductible? ANSWER: The deductible is the dollar amount (shown in the Schedule of Benefits) that you and your eligible Dependents are responsible to pay before the Medical Expense
Additional shareholder information
Additional shareholder information SPIRE HEALTHCARE WEBSITE Shareholders are encouraged to visit our website at www.spirehealthcare.com which has a wealth of information about the Company and the services
Additional shareholder information
SHAREHOLDER INFORMATION: ADDITIONAL SHAREHOLDER INFORMATION Additional shareholder information Spire Healthcare website Shareholders are encouraged to visit our website at www.spirehealthcare.com which
Annual Report
New England Tablelands County Council Trading as New England Weeds Authority Annual Report 2014 2015 Adopted by Council 28 October 2015 Our Environment Our Community Our Council Our Responsibility This
The Impact of Cost Shifting on NSW Local Government: A Survey of Councils - Financial Year 2010/11 -
The Impact of Cost Shifting on NSW Local Government: A Survey of Councils - Financial Year 2010/11 - Report by the Local Government and Shires Associations of NSW 2012 KEY FINDINGS Survey baseline (questions
HALF-YEAR REPORT 2017 BUILDING ON SUCCESS
HALF-YEAR REPORT 2017 BUILDING ON SUCCESS WWW.BASILEA.COM OUR COMPANY OUR VISION Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company developing and bringing to the market products
The Importance of the Health Care Sector to the Kansas Economy
The Importance of the Health Care Sector to the Kansas Economy Kansas Hospital Association January 2018 John Leatherman, Director, Office of Local Government Funding for this report supports KansasHealthMatters
SAMPLE SUPERANNUATION FUND MEMBER'S SUMMARY REPORT AT 30 JUNE 2009
SAMPLE SUPERANNUATION FUND MEMBER'S SUMMARY REPORT AT 30 JUNE 2009 Member's Details O/B Increases Decreases C/B Contrib Tra In Profit Ins Pol Tax Exp Ins Pol Tra Out Ben Pd SMITH, JOHN 178,156 48,000 9,609
Basilea Pharmaceutica
Basilea Pharmaceutica Strength in numbers FY results Pharma & biotech Basilea reported a definable FY17, as a multitude of licensing/distribution agreements announced in 2016/17 for launched anti-infective
Introducing the Healthcare Property Trust
Introducing the Healthcare Property Trust The Healthcare Property Trust opened in 1999 to capitalise on Australia s ageing population and growing demands for healthcare. Over the last 13 years, the Trust
Figgs Eye Clinic and Optical / Wilson Contact Lens 1410 Lakeside Court #103 Yakima, WA Phone: Fax:
Figgs Eye Clinic and Optical / Wilson Contact Lens 1410 Lakeside Court #103 Yakima, WA 98902 Phone: 453-2010 Fax: 225-6421 Patient Name: Last: First: Middle Initial: Nickname: Sex: M / F Date of Birth:
Credit and Debit Cards
Credit and Debit Cards VALID FROM MONTH/YEAR MONTH/YEAR GOOD THRU VALID FROM MONTH/YEAR MONTH/YEAR GOOD THRU No expensive reward system, just everyday value Northern Inland offers a cost-effective Visa
The AUD, rates, and the changing face of the Australian economy
The AUD, rates, and the changing face of the Australian economy Presentation to Australian Association of Agricultural Consultants Outlook Day, Hyatt Regency, Perth, WA David de Garis, Director and Senior
Corporate Performance Report 2015/16
Bod/76/15 Corporate Performance Report 2015/16 May 2015 OUR VISION: OUR MISSION: To be known as one of the top ten hospital Trusts in England and the Kent hospital of choice for patients and those close
COMPANY DESCRIPTION SUMMARY. See Important Disclosures and Disclaimers at the end of this report. 1 9/8/16
9/8/16 Laura S. Engel, CPA laura@stonegateinc.com 214-987- 4121 MARKET STATISTICS Exchange / Symbol CONDENSED BALANCE SHEET ($mm, except per share data) NASDAQ: OCLS Price: $4.13 Market Cap ($mm): $17.3
PUBLIC AUDIT AND POST-LEGISLATIVE SCRUTINY COMMITTEE AGENDA. 27th Meeting, 2017 (Session 5) Thursday 16 November 2017
PAPLS/S5/17/27/A PUBLIC AUDIT AND POST-LEGISLATIVE SCRUTINY COMMITTEE AGENDA 27th Meeting, 2017 (Session 5) Thursday 16 November 2017 The Committee will meet at 9.00 am in the David Livingstone Room (CR6).
ADMISSION DOCUMENT. SoftOx Solutions AS
ADMISSION DOCUMENT SoftOx Solutions AS (A private limited company organized under the Norwegian Limited Liability Companies Act with business reg. no 998516390) This Admission Document has been prepared
NuCoal to acquire Plashett Coal Project
ASX Announcement 20 February 2012 NuCoal to acquire Plashett Coal Project Highlights: Plashett Coal Project is located strategically between NuCoal s existing Doyles Creek and Savoy Hill Projects. Plashett
Population health profile of the. Northern Rivers. Division of General Practice: supplement
Population health profile of the Northern Rivers Division of General Practice: supplement Population Profile Series: No. 3a PHIDU March 007 Copyright Commonwealth of 007 This work may be reproduced and
Medicare Inpatient Rehabilitation Facility Prospective Payment System
Medicare Inpatient Rehabilitation Facility Prospective Payment System Payment Rule Brief FINAL RULE Program Year: FFY 2016 Overview and Resources On August 6, 2015, the Centers for Medicare and Medicaid
SUMMARY: The Food Safety and Inspection Service (FSIS) is. proposing to amend the Federal meat inspection regulations to
This document is scheduled to be published in the Federal Register on 02/01/2018 and available online at https://federalregister.gov/d/2018-01256, and on FDsys.gov Billing Code 3410-DM-P DEPARTMENT OF
Integrated Report 2018 Year ended March 31, 2018 GOING FORWARD. Continuing to Succeed as a Drug Discovery-Based Pharmaceutical Company
Integrated Report 2018 Year ended March 31, 2018 GOING FORWARD Continuing to Succeed as a Drug Discovery-Based Pharmaceutical Company CONTENTS 02 To Our Stakeholders 03 The Company Policy of Shionogi 04
Analysis of small business retail energy bills in Australia
Analysis of small business retail energy bills in Australia Final Report, December 2017 Small and Medium Enterprise (SME) Retail Tariff Tracker Project Prepared by Alviss Consulting, with Energy Consumers
STUDY MEDICAID COVERAGE FOR VISUAL AIDS. Session Law , Section 12H.6A
STUDY MEDICAID COVERAGE FOR VISUAL AIDS Session Law 2015-241, Section 12H.6A Report to the Joint Legislative Oversight Committee on Health and Human Services and The Fiscal Research Division by North Carolina
DO WE NEED TO CONSIDER FLOODS RARER THAN 1% AEP?
DO WE NEED TO CONSIDER FLOODS RARER THAN 1% AEP? Drew Bewsher and John Maddocks Bewsher Consulting Pty Ltd Abstract Everyone is aware that floods rarer than the 1% AEP event occur. Australia-wide, over
Gilead Sciences Announces Record Third Quarter 2009 Financial Results
Gilead Sciences Announces Record Third Quarter 2009 Financial Results - Record Total Revenues of $1.80 Billion, Up 31 Percent over Third Quarter 2008 - - Record Product Sales of $1.65 Billion, Up 23 Percent
(6) DEDUCTIBLES Same as above North Dakota s statute does not contain language relating to deductible requirements for immunization services.
SUMMARY TABLE NORTH DAKOTA PROPOSED LANGUAGE Covered Services: To the extent permitted by federal law, any health benefit plan issued, renewed, extended, or modified for delivery in this state, must include
THC Quarterly Update and Appendix 4C
www.thcl.com.au ASX RELEASE (31 OCTOBER 2018) To be renamed THC Global Group Limited (subject to shareholder approval) THC Quarterly Update and Appendix 4C The Hydroponics Company Limited, to be renamed
MINNESOTA-- Elements of a Comprehensive Immunization Coverage Insurance Statute
SUMMARY TABLE--MINNESOTA PROPOSED LANGUAGE Covered Services: To the extent permitted by federal law, any health benefit plan issued, renewed, extended, or modified for delivery in this state, must include
(3) FOLLOWS ACIP RECOMMENDATIONS
SUMMARY TABLE DISTRICT OF COLUMBIA PROPOSED LANGUAGE Covered Services: To the extent permitted by federal law, any health benefit plan issued, renewed, extended, or modified for delivery in this state,
ARCH BIOPARTNERS INC. MANAGEMENT DISCUSSION AND ANALYSIS:
ARCH BIOPARTNERS INC. MANAGEMENT DISCUSSION AND ANALYSIS: FOR THE QUARTER ENDED MARCH 31, 2017 DATED MAY 30, 2017 i The following Management Discussion and Analysis( MD&A ) should be read in conjunction
Corporate Performance Report 2013/14
BoD/04/14 Corporate Performance Report 2013/14 December 2013 OUR VISION: OUR MISSION: To be known as one of the top ten hospital Trusts in England and the Kent hospital of choice for patients and those
Supplementary material of: The nosocomial transmission rate of animal-associated ST398 methicillin-resistant Staphylococcus aureus
Supplementary material of: The nosocomial transmission rate of animal-associated ST398 methicillin-resistant Staphylococcus aureus Martin C.J. Bootsma, Marjan W.M. Wassenberg, Pieter Trapman, Marc J.M.
H1 Results Conference Call Business Progress and H1 Financial results September 6 th, Polyphor Ltd 2018 Half Year Results Presentation
H1 Results Conference Call Business Progress and H1 Financial results September 6 th, 2018 1 Disclaimer This presentation (the Presentation ) has been prepared by Polyphor Ltd. ( the Company and together
ANNUAL REPORT Join us and make a difference. Armidale Diocesan Investment Group adig.com.au
ANNUAL REPORT 2017 Join us and make a difference Armidale Diocesan Investment Group adig.com.au Armidale Office Unit 1 131 Barney St Armidale NSW 2350 FREECALL 1800 040 903 Phone: 02 6772 8311 Fax: 02
Basilea Pharmaceutica Ltd. Annual Report 2011 Basilea in brief. Our company
Annual REPORT 2011 Basilea Pharmaceutica Ltd. Annual Report 2011 Basilea in brief Basilea in brief Our company Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss
ANNUAL BUSHFIRE RISK MANAGEMENT REPORT 2016/17. Annual Bushfire Risk Management Report 2016/17 Page 1 of Prepared by: Essential Energy
ANNUAL BUSHFIRE RISK MANAGEMENT REPORT 2016/17 Page 1 of 9 20.11.17 Prepared by: Essential Energy 1. Introduction Essential Energy s Annual Bushfire Risk Management Report is provided in accordance with
SAVARA INC. (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 April 27, 2017 Date of Report (Date